Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakkum

Showing results (201-210 of 347) with videos related to

Pageof 35
Sort By:
Gynecologic Oncology|April 28, 2015
Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancerJo Marie Tran Janco, Gretchen Glaser, Bohyun Kim, et al.
Attachment & Human Development|May 12, 2021
Six attachment discourses: convergence, divergence and relayRobbie Duschinsky, Lianne Bakkum, Julia M M Mannes, et al.
Gynecologic Oncology|September 27, 2017
Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analysesAmanika Kumar, Callie C Hurtt, William A Cliby, et al.
Msphere|September 8, 2025
Using BONCAT to dissect the proteome of <i>S. aureus</i> persistersEva D C George Matlalcuatzi, Thomas Bakkum, Pooja S Thomas, et al.
Obstetrics and Gynecology|December 24, 2008
Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancerJamie N Bakkum-Gamez, Debra L Richardson, Leigh G Seamon, et al.
Gynecologic Oncology|December 16, 2014
Surgical site infection after primary surgery for epithelial ovarian cancer: predictors and impact on survivalChristine W Tran, Michaela E McGree, Amy L Weaver, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 16, 2011
Is there a high-risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy?Jamie N Bakkum-Gamez, Debra L Richardson, Leigh G Seamon, et al.
Gynecologic Oncology|January 3, 2012
Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control studyM M AlHilli, S C Dowdy, A L Weaver, et al.
Spinal Cord|January 28, 2015
Effects of hybrid cycling versus handcycling on wheelchair-specific fitness and physical activity in people with long-term spinal cord injury: a 16-week randomized controlled trialA J T Bakkum, S de Groot, J M Stolwijk-Swüste, et al.
Gynecologic Oncology|June 22, 2018
Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operabilityDiogo Torres, Chen Wang, Amanika Kumar, et al.
Pageof 35

Showing results (201-210 of 347) with videos related to

Sort By:
Pageof 35
Gynecologic Oncology|April 28, 2015
Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancerJo Marie Tran Janco, Gretchen Glaser, Bohyun Kim, et al.
Attachment & Human Development|May 12, 2021
Six attachment discourses: convergence, divergence and relayRobbie Duschinsky, Lianne Bakkum, Julia M M Mannes, et al.
Gynecologic Oncology|September 27, 2017
Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analysesAmanika Kumar, Callie C Hurtt, William A Cliby, et al.
Msphere|September 8, 2025
Using BONCAT to dissect the proteome of <i>S. aureus</i> persistersEva D C George Matlalcuatzi, Thomas Bakkum, Pooja S Thomas, et al.
Obstetrics and Gynecology|December 24, 2008
Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancerJamie N Bakkum-Gamez, Debra L Richardson, Leigh G Seamon, et al.
Gynecologic Oncology|December 16, 2014
Surgical site infection after primary surgery for epithelial ovarian cancer: predictors and impact on survivalChristine W Tran, Michaela E McGree, Amy L Weaver, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 16, 2011
Is there a high-risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy?Jamie N Bakkum-Gamez, Debra L Richardson, Leigh G Seamon, et al.
Gynecologic Oncology|January 3, 2012
Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control studyM M AlHilli, S C Dowdy, A L Weaver, et al.
Spinal Cord|January 28, 2015
Effects of hybrid cycling versus handcycling on wheelchair-specific fitness and physical activity in people with long-term spinal cord injury: a 16-week randomized controlled trialA J T Bakkum, S de Groot, J M Stolwijk-Swüste, et al.
Gynecologic Oncology|June 22, 2018
Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operabilityDiogo Torres, Chen Wang, Amanika Kumar, et al.
Pageof 35